1. Home
  2. DOMH vs XBIT Comparison

DOMH vs XBIT Comparison

Compare DOMH & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dominari Holdings Inc.

DOMH

Dominari Holdings Inc.

N/A

Current Price

$0.85

Market Cap

53.1M

Sector

Health Care

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.95

Market Cap

57.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DOMH
XBIT
Founded
1967
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
57.6M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
DOMH
XBIT
Price
$0.85
$1.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 159.5K
82.6K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
★ 121.20%
N/A
EPS Growth
★ 34.03
N/A
EPS
N/A
★ N/A
Revenue
★ $123,104,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$30.47
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 578.41
N/A
52 Week Low
$0.70
$1.80
52 Week High
$5.10
$2.73

Technical Indicators

Market Signals
Indicator
DOMH
XBIT
Relative Strength Index (RSI) 18.83 45.36
Support Level N/A $1.83
Resistance Level $3.33 $2.42
Average True Range (ATR) 0.15 0.11
MACD -0.08 0.01
Stochastic Oscillator 8.24 45.45

Price Performance

Historical Comparison
DOMH
XBIT

About DOMH Dominari Holdings Inc.

Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: